Pitt-SDRC: A Center to Improve Care for AKI Survivors
Official title: The Pittsburgh Scientific and Data Research Center for the COPE-AKI Consortium (Pitt-SDRC)
Funded at University of Pittsburgh at Pittsburgh · NIH-11554143 · Data updated 2026-11-12
A coordinated center aims to improve follow-up care and treatment for people who have survived moderate to severe acute kidney injury.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | July 19, 2021 |
| Project end | June 30, 2028 |
| Funding year | 2026 |
| Award (this year) | $685,250 |
| NIH project number | 3U01DK130010-06S1 |
| Project ID | NIH-11554143 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults who have survived an episode of moderate to severe AKI (stage 2 or stage 3) and are transitioning from hospital to home or outpatient care.
✕Less likely to help
Patients who did not experience AKI or whose condition is unrelated to kidney injury may not directly benefit.
What this research studies
If you’ve had a serious kidney injury, this project looks for better ways to manage your care after you leave the hospital. It will test practical interventions to ensure timely follow-up, safer medications, and clearer information about what you should do next. The project brings together experts in kidney disease, statistics, and clinical trials to study what actually helps patients live healthier lives after AKI. The goal is to reduce complications, improve quality of life, and prevent further kidney problems.
Why it matters
Potential benefit: If successful, this work could lead to clearer post-AKI care plans and better medication strategies to protect kidney health.
How similar studies have gone: Past studies show that structured follow-up can improve outcomes after AKI, but optimal approaches remain unclear and need confirmation in diverse settings.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Abebe, Kaleab Z — University of Pittsburgh at Pittsburgh
- Study coordinator: Abebe, Kaleab Z
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.